A phase I trial of caffeine to evaluate safety in infants with hypoxic-ischemic encephalopathy.
Wesley M JacksonDaniel GonzalezRachel Gottron GreenbergYueh Z LeeMatthew M LaughonPublished in: Journal of perinatology : official journal of the California Perinatal Association (2023)
ClinicalTrials.gov Identifier: NCT03913221.